The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term oncologic outcomes in elderly patients with localized anal cancer.
 
Camila Venchiarutti Moniz
Honoraria - Libbs
Research Funding - BMS; Immix BioPharma; Jazz Pharmaceuticals; Merck; Servier/Pfizer; Takeda
Travel, Accommodations, Expenses - Libbs; Merck
 
Renata Bonadio
Consulting or Advisory Role - Ache Company; MSD
Speakers' Bureau - Adium Pharma; AstraZeneca; BMS Brazil; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; MSD; Nestle health science; Pfizer
Research Funding - AstraZeneca (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Daiichi Sankyo/Astra Zeneca; MSD; MSD
 
Letícia Estanislau
No Relationships to Disclose
 
Maria Braghiroli
No Relationships to Disclose
 
Murilo Pacheco De Mello
No Relationships to Disclose
 
Denis Galhera
No Relationships to Disclose
 
Carolina Victor
No Relationships to Disclose
 
Carlos Frederico Marques
No Relationships to Disclose
 
Luciana Alban
No Relationships to Disclose
 
Andre Chen
No Relationships to Disclose
 
Caio Nahas
No Relationships to Disclose
 
Jorge Sabbaga
Speakers' Bureau - Abbott Laboratories
 
Paulo Hoff
Leadership - Oncologia D’Or
Stock and Other Ownership Interests - Oncostar
Honoraria - Bayer Health (I); United medical (I)
Consulting or Advisory Role - AstraZeneca (Inst); Bayer (I); EMS; EMS; Exelixis (I); Lilly (I); United Health Group (I)
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); BMS Brazil (Inst); Daiichi Sankyo/Astra Zeneca (Inst); Exelixis (Inst); Lilly (I); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca